JULIE SEIFERT: Open Payments
NPI 1982029435 · IRWIN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 25 payments from 11 companies in 2025. Trend: 2023 $166 · 2024 $16 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $118 |
| Novo Nordisk Inc | 5 | $88 |
| ABBVIE INC. | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Viatris Specialty LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Astellas Pharma US Inc | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| Organon LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: NURTEC ODT, CAPLYTA, QULIPTA, Rybelsus, YUPELRI, ELIQUIS, AIRSUPRA, Veozah.
Industry payments across PA — which companies pay providers there.
